Filing Details

Accession Number:
0001654954-25-001505
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Camber Capital Management
Company:
Ptc Therapeutics Inc. (NASDAQ:PTCT)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Camber Capital Management LP 0 3,200,000 4.15%
Stephen DuBois 0 3,200,000 4.15%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Camber Capital Management LP
 
Signature:/s/ Sean George
Name/Title:Sean George, Chief Financial Officer
Date:02/14/2025
 
Signature:/s/ Stephen DuBois
Name/Title:Stephen DuBois, individually
Date:02/14/2025
 
Stephen DuBois
 
Signature:/s/ Sean George
Name/Title:Sean George, Chief Financial Officer
Date:02/14/2025
 
Signature:/s/ Stephen DuBois
Name/Title:Stephen DuBois, individually
Date:02/14/2025
Exhibit Information

Exhibit 1 - Joint Filing Agreement